Roche shared details of its plans to enter the continuous glucose monitor (CGM) market, unveiling the Accu-Chek Smartguide at the Advanced Technologies and Treatments for Diabetes conference in Florence, Italy.
On Thursday, the company released data on a 14-day sensor that could compete with Abbott and Dexcom for the CGM market. Roche is working to get a CE mark and plans to sell the device in “selected European countries” soon after receiving clearance.
